High drug prices have been a focus of Congress and the Trump Administration for the past year, with insulin becoming the prime example of the negative impact increasing drug prices are having on patients. The Endocrine Society has made addressing the high cost of insulin a priority for the past three years. We have urged...
A novel way to reach even more patients, clinicians, and researchers is to take your endocrinology skill into the business world. Here we highlight an ENDO 2020 session that will show attendees how industry could be a viable route for researchers and physicians alike. Last year, at ENDO 2019 in New Orleans, three entrepreneurs at...
The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session. Several states are considering legislation that would carry penalties of jail time and fines for healthcare providers who treat transgender teenagers using evidence-based practices. These...
After months of bargaining and numerous stalemates, the House of Representatives and Senate reached agreement on Fiscal Year 2020 appropriations just before funding expired on December 20. The deal also provided a “Christmas Tree” legislative vehicle for various policy measures. The spending deal was divided into two packages of individual bills covering funding for every...
The Endocrine Society sent a delegation, including members Amanda Bell and Shivani Agarwal, to participate in the American Medical Association (AMA) House of Delegates (HOD) in November to establish policy positions on topics of importance to endocrinologists and the patients they treat. We attend the AMA meetings to further our policy agenda by garnering the support of...
There is no shortage of interesting things going on in Washington, D.C., these days, from impeachment inquiries to funding the government to deciding on a Democratic nominee for the 2020 election. On September 28, our clinical leaders came to Washington to use their voice to advocate for a range of issues, including the renewal of...
The Endocrine Society is a leading advocate on several issues that would increase access to diabetes coverage and funding for important research. See below for recent highlights of our activities concerning the reauthorization of the Special Diabetes Program, insulin affordability, and diabetes testing supplies. Special Diabetes Program – Ensuring continuation of the Special Diabetes Program...
Endocrine Society member and diabetes expert Alvin C. Powers, MD, will testify before the House Energy & Commerce Subcommittee on Oversight and Investigations Tuesday about the rising cost of insulin and the challenges this poses for individuals with diabetes who depend on the life-saving drug. As director of the Vanderbilt Diabetes Center and Chief of...
There is no shortage of interesting things going on in Washington, D.C., these days, from impeachment inquiries to funding the government to deciding on a Democratic nominee for the 2020 election. On September 28, our clinical leaders came to Washington to use their voice to advocate for a range of issues, including the renewal of...
